These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2062621)

  • 1. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
    Black SB; Shinefield HR; Fireman B; Hiatt R; Polen M; Vittinghoff E
    Pediatr Infect Dis J; 1991 Feb; 10(2):97-104. PubMed ID: 2062621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
    Black SB; Shinefield HR; Lampert D; Fireman B; Hiatt RA; Polen M; Vittinghoff E
    Pediatr Infect Dis J; 1991 Feb; 10(2):92-6. PubMed ID: 2062620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
    Black SB; Shinefield HR
    Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
    Booy R; Heath PT; Slack MP; Begg N; Moxon ER
    Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.
    Black SB; Shinefield HR; Fireman B; Hiatt R
    J Infect Dis; 1992 Jun; 165 Suppl 1():S139-43. PubMed ID: 1588149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 1995 Nov; 14(11):978-81. PubMed ID: 8584366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age.
    Hay JW; Daum RS
    Pediatr Infect Dis J; 1990 Apr; 9(4):246-52. PubMed ID: 2110651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group.
    Black SB; Shinefield HR; Ray P; Lewis EM; Fireman B; Hiatt R; Madore DV; Johnson CL; Hackell JG
    Pediatr Infect Dis J; 1993 Dec; 12(12):981-5. PubMed ID: 8108224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
    Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
    Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b.
    Letson GW; Santosham M; Reid R; Priehs C; Burns B; Jahnke A; Gahagan S; Nienstadt L; Johnson C; Smith D
    Pediatr Infect Dis J; 1988 Nov; 7(11):747-52. PubMed ID: 3266005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine.
    Murphy TV; Pastor P; Medley F; Osterholm MT; Granoff DM
    J Pediatr; 1993 Apr; 122(4):517-23. PubMed ID: 8463894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Haemophilus influenzae-diphtheria CRM197 protein conjugate vaccine (HbOC) in Libyan infants.
    Hadida M; Cuevas LE; Moghadami A; Baccoosh M; Gurgel RQ; Hart CA
    Trop Med Int Health; 1998 Feb; 3(2):95-9. PubMed ID: 9537270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study.
    Vadheim CM; Greenberg DP; Eriksen E; Hemenway L; Christenson P; Ward B; Mascola L; Ward JI
    Pediatr Infect Dis J; 1994 Apr; 13(4):274-80. PubMed ID: 8036043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.